Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,945.00
+18.00 (0.93%)
Oct 1, 2026, 3:29 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 493 billion as of October 1, 2026. Its market cap has increased by 45.12% in one year.
Market Cap
493.00B
Enterprise Value
503.73B
Revenue
101.26B
Ranking
n/a
PE Ratio
37.64
Stock Price
1,945.00
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 493.00B, an increase of 15,216.44%. That is a compound annual growth rate of 22.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 493.00B | 36.95% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.11T |
| Laurus Labs | 1.07T |
| Mankind Pharma | 1.03T |
| Aurobindo Pharma | 976.82B |
| Glenmark Pharmaceuticals | 688.99B |
| Alkem Laboratories | 627.72B |
| Gland Pharma | 493.20B |
| Ajanta Pharma | 444.46B |